MorphoSys AG buy pheinen
Start price
03.04.12
/
50%
€19.98
Target price
19.04.12
€21.20
Performance (%)
7.11%
End price
19.04.12
€21.40
Summary
This prediction ended on 19.04.12 with a price of €21.40. With a performance of 7.11%, the BUY prediction by pheinen for MorphoSys AG closed with a slight gain. pheinen has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -3.542% | -3.542% | 243.495% | -16.900% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by pheinen for this prediction
In the thread Morphosys AG diskutieren
Aktienrückkauf
Es brodelt in der Pipeline und ich schätze der Kurs wird ebenfalls nach oben wandern :)